Benjamin Gerendash
Articles
-
May 24, 2024 |
targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash
2 Commerce Drive Cranbury, NJ 08512
-
May 3, 2024 |
targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash
2 Commerce Drive Cranbury, NJ 08512
-
Apr 26, 2024 |
targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash
Sumanta Kumar Pal, MD, FASCO, reviews data from the TIVO-3 study investigating tivozanib in patients with advanced renal cell carcinoma, and the panel offers its impressions on the results.
-
Apr 26, 2024 |
targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash
2 Commerce Drive Cranbury, NJ 08512
-
Apr 10, 2024 |
targetedonc.com | Sumanta Kumar Pal |Thomas Hutson |Rana R. McKay |Benjamin Gerendash
2 Commerce Drive Cranbury, NJ 08512
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →